Tapewire

Nasdaq · USD

BLFS

BIOLIFE SOLUTIONS INC

Export transactions ↓
Tapewire entity
4614
SEC CIK
0000834365
Parsed reports
1,001

Last 12 months

Inside the activity.

0 purchase rows · 39 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025014
Dec 202508
Jan 202605
Feb 202600
Mar 202609
Apr 202600
May 202603
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
October 20, 2021 Filed Oct 21, 2021 00:00 UTC
Mathew Aby J.EVP & Chief Scientific Officer
SaleCommon Stock 10,000 $41.97 $419,700.00
Disclosure

SEC source: 0001437749-21-023993 · rdgdoc.xml · nonDerivative · entry 4

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 207,198

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of November 12, 2020.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.66 to $42.36, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
October 20, 2021 Filed Oct 21, 2021 00:00 UTC
Mathew Aby J.EVP & Chief Scientific Officer
Exercise / conversionCommon Stock 10,000 $1.64 $16,400.00
Disclosure

SEC source: 0001437749-21-023993 · rdgdoc.xml · nonDerivative · entry 3

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 217,198

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 20, 2021 Filed Oct 23, 2021 00:00 UTC
Schulz MarcusChief Revenue Officer
SaleCommon Stock 399 $42.34 $16,893.66
Disclosure

SEC source: 0001437749-21-024188 · rdgdoc.xml · nonDerivative · entry 1

Schulz Marcus · CIK 0001812702 · Chief Revenue Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,803

F1 · kind: The sale reported herein was made by the issuer to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
October 20, 2021 Filed Oct 23, 2021 00:00 UTC
Aebersold SarahVP, Global Human Resources
SaleCommon Stock 272 $42.34 $11,516.48
Disclosure

SEC source: 0001437749-21-024187 · rdgdoc.xml · nonDerivative · entry 1

Aebersold Sarah · CIK 0001837756 · VP, Global Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,568

F1 · kind: The sale reported herein was made by the issuer to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
October 18, 2021 Filed Oct 21, 2021 00:00 UTC
Mathew Aby J.EVP & Chief Scientific Officer
Exercise / conversionEmployee Stock Option · Derivative 10,000 $0.00 Strike: $1.64 $0.00
Disclosure

SEC source: 0001437749-21-023993 · rdgdoc.xml · derivative · entry 5

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,853

Underlying: Common Stock · 10,000 shares

Expires 2021-12-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: On December 20, 2016, the reporting person was granted an option to purchase 197,707 shares of common stock which vested in two equal annual installments on March 8, 2018 and March 8, 2019.

Read SEC document
October 18, 2021 Filed Oct 21, 2021 00:00 UTC
Mathew Aby J.EVP & Chief Scientific Officer
SaleCommon Stock 10,000 $41.34 $413,400.00
Disclosure

SEC source: 0001437749-21-023993 · rdgdoc.xml · nonDerivative · entry 2

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 207,198

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of November 12, 2020.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.70 to $41.82, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
October 18, 2021 Filed Oct 21, 2021 00:00 UTC
Mathew Aby J.EVP & Chief Scientific Officer
Exercise / conversionCommon Stock 10,000 $1.64 $16,400.00
Disclosure

SEC source: 0001437749-21-023993 · rdgdoc.xml · nonDerivative · entry 1

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 217,198

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 15, 2021 Filed Oct 19, 2021 00:30 UTC
Berard ToddChief Marketing Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 6,160 $0.00 Strike: $1.64 $0.00
Disclosure

SEC source: 0001437749-21-023855 · rdgdoc.xml · derivative · entry 7

Berard Todd · CIK 0001633186 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,320

Underlying: Common Stock · 6,160 shares

Expires 2021-12-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: On December 20, 2016, the reporting person was granted an option to purchase 123,209 shares of common stock which vested in two equal annual installments on March 8, 2018 and March 8, 2019.

Read SEC document
October 15, 2021 Filed Oct 19, 2021 00:30 UTC
Berard ToddChief Marketing Officer
SaleCommon Stock 6,160 $40.76 $251,081.60
Disclosure

SEC source: 0001437749-21-023855 · rdgdoc.xml · nonDerivative · entry 5

Berard Todd · CIK 0001633186 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,664

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2020.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.70 to $41.54, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
October 15, 2021 Filed Oct 19, 2021 00:30 UTC
Berard ToddChief Marketing Officer
Exercise / conversionCommon Stock 6,160 $1.64 $10,102.40
Disclosure

SEC source: 0001437749-21-023855 · rdgdoc.xml · nonDerivative · entry 4

Berard Todd · CIK 0001633186 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,824

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 14, 2021 Filed Oct 19, 2021 00:32 UTC
Mathew Aby J.EVP & Chief Scientific Officer
SaleCommon Stock 1,273 $39.97 $50,881.81
Disclosure

SEC source: 0001437749-21-023859 · rdgdoc.xml · nonDerivative · entry 1

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 207,198

F1 · kind: The sale reported herein was made by the issuer to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
October 14, 2021 Filed Oct 19, 2021 00:31 UTC
Foster Karen A.Chief Quality Officer
SaleCommon Stock 1,082 $39.97 $43,247.54
Disclosure

SEC source: 0001437749-21-023858 · rdgdoc.xml · nonDerivative · entry 1

Foster Karen A. · CIK 0001683151 · Chief Quality Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,760

F1 · kind: The sale reported herein was made by the issuer to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
October 14, 2021 Filed Oct 19, 2021 00:31 UTC
Rice MichaelDirector · CEO
SaleCommon Stock 3,215 $39.97 $128,503.55
Disclosure

SEC source: 0001437749-21-023857 · rdgdoc.xml · nonDerivative · entry 1

Rice Michael · CIK 0001389512 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 261,340

F1 · kind: The sale reported herein was made by the issuer to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
October 14, 2021 Filed Oct 19, 2021 00:30 UTC
DE GREEF RODERICKChief Financial Officer
SaleCommon Stock 1,221 $39.97 $48,803.37
Disclosure

SEC source: 0001437749-21-023856 · rdgdoc.xml · nonDerivative · entry 1

DE GREEF RODERICK · CIK 0001241181 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 126,704

F1 · kind: The sale reported herein was made by the issuer to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
October 14, 2021 Filed Oct 19, 2021 00:30 UTC
Berard ToddChief Marketing Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 6,160 $0.00 Strike: $1.64 $0.00
Disclosure

SEC source: 0001437749-21-023855 · rdgdoc.xml · derivative · entry 6

Berard Todd · CIK 0001633186 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,480

Underlying: Common Stock · 6,160 shares

Expires 2021-12-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: On December 20, 2016, the reporting person was granted an option to purchase 123,209 shares of common stock which vested in two equal annual installments on March 8, 2018 and March 8, 2019.

Read SEC document
October 14, 2021 Filed Oct 19, 2021 00:30 UTC
Berard ToddChief Marketing Officer
SaleCommon Stock 6,160 $39.91 $245,845.60
Disclosure

SEC source: 0001437749-21-023855 · rdgdoc.xml · nonDerivative · entry 3

Berard Todd · CIK 0001633186 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,664

F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2020.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.48 to $40.17, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
October 14, 2021 Filed Oct 19, 2021 00:30 UTC
Berard ToddChief Marketing Officer
Exercise / conversionCommon Stock 6,160 $1.64 $10,102.40
Disclosure

SEC source: 0001437749-21-023855 · rdgdoc.xml · nonDerivative · entry 2

Berard Todd · CIK 0001633186 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,824

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 14, 2021 Filed Oct 19, 2021 00:30 UTC
Berard ToddChief Marketing Officer
SaleCommon Stock 895 $39.92 $35,728.40
Disclosure

SEC source: 0001437749-21-023855 · rdgdoc.xml · nonDerivative · entry 1

Berard Todd · CIK 0001633186 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,664

F1 · kind: The sale reported herein was made by the issuer to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
October 11, 2021 Filed Oct 14, 2021 00:09 UTC
Schulz MarcusChief Revenue Officer
SaleCommon Stock 245 $38.22 $9,363.90
Disclosure

SEC source: 0001437749-21-023621 · rdgdoc.xml · nonDerivative · entry 1

Schulz Marcus · CIK 0001812702 · Chief Revenue Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,202

F1 · kind: The sale reported herein was made by the issuer to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
October 07, 2021 Filed Oct 8, 2021 01:26 UTC
Rice MichaelDirector · CEO
Exercise / conversionEmployee Stock Option · Derivative 11,461 $0.00 Strike: $1.64 $0.00
Disclosure

SEC source: 0001437749-21-023466 · rdgdoc.xml · derivative · entry 6

Rice Michael · CIK 0001389512 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,847

Underlying: Common Stock · 11,461 shares

Expires 2021-12-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The option vested in two equal annual installments based on the registrant's satisfaction of certain performance criteria for the fiscal year ending December 2017. The performance criteria for 2017 were met, resulting in vesting of the option as follows: 114,613 shares vested on March 8, 2018 and 114,613 shares vested on March 8, 2019.

Read SEC document
October 07, 2021 Filed Oct 8, 2021 01:26 UTC
Rice MichaelDirector · CEO
SaleCommon Stock 11,461 $40.55 $464,743.55
Disclosure

SEC source: 0001437749-21-023466 · rdgdoc.xml · nonDerivative · entry 4

Rice Michael · CIK 0001389512 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 264,555

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of November 12, 2020.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.81 to $40.92, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
October 07, 2021 Filed Oct 8, 2021 01:26 UTC
Rice MichaelDirector · CEO
Exercise / conversionCommon Stock 11,461 $1.64 $18,796.04
Disclosure

SEC source: 0001437749-21-023466 · rdgdoc.xml · nonDerivative · entry 3

Rice Michael · CIK 0001389512 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 276,016

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 07, 2021 Filed Oct 13, 2021 00:00 UTC SaleCommon Stock 2,000 $39.96 $79,920.00
Disclosure

SEC source: 0001437749-21-023553 · rdgdoc.xml · nonDerivative · entry 3

Schick Joseph C · CIK 0001592238 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,625

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.87 to $40.08, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
October 07, 2021 Filed Oct 13, 2021 00:00 UTC SaleCommon Stock 625 $40.08 $25,050.00
Disclosure

SEC source: 0001437749-21-023553 · rdgdoc.xml · nonDerivative · entry 2

Schick Joseph C · CIK 0001592238 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,625

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.0801 to $40.0835, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
October 07, 2021 Filed Oct 13, 2021 00:00 UTC SaleCommon Stock 625 $40.28 $25,175.00
Disclosure

SEC source: 0001437749-21-023553 · rdgdoc.xml · nonDerivative · entry 1

Schick Joseph C · CIK 0001592238 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,250

F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

Read SEC document
October 05, 2021 Filed Oct 8, 2021 01:26 UTC
Rice MichaelDirector · CEO
Exercise / conversionEmployee Stock Option · Derivative 11,461 $0.00 Strike: $1.64 $0.00
Disclosure

SEC source: 0001437749-21-023466 · rdgdoc.xml · derivative · entry 5

Rice Michael · CIK 0001389512 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,308

Underlying: Common Stock · 11,461 shares

Expires 2021-12-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The option vested in two equal annual installments based on the registrant's satisfaction of certain performance criteria for the fiscal year ending December 2017. The performance criteria for 2017 were met, resulting in vesting of the option as follows: 114,613 shares vested on March 8, 2018 and 114,613 shares vested on March 8, 2019.

Read SEC document
October 05, 2021 Filed Oct 8, 2021 01:26 UTC
Rice MichaelDirector · CEO
SaleCommon Stock 11,461 $40.63 $465,660.43
Disclosure

SEC source: 0001437749-21-023466 · rdgdoc.xml · nonDerivative · entry 2

Rice Michael · CIK 0001389512 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 264,555

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of November 12, 2020.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.12 to $41.08, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
October 05, 2021 Filed Oct 8, 2021 01:26 UTC
Rice MichaelDirector · CEO
Exercise / conversionCommon Stock 11,461 $1.64 $18,796.04
Disclosure

SEC source: 0001437749-21-023466 · rdgdoc.xml · nonDerivative · entry 1

Rice Michael · CIK 0001389512 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 276,016

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 01, 2021 Filed Oct 8, 2021 00:01 UTC GrantCommon Stock 2,938 Not disclosed Not disclosed
Disclosure

SEC source: 0001437749-21-023465 · rdgdoc.xml · nonDerivative · entry 1

GOSWAMI JOYDEEP · CIK 0001533115 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,938

F1 · price: The restricted stock was granted pursuant to the BioLife Solutions 2013 Performance Incentive Plan and vests on the twelve-month anniversary of the grant date.

Read SEC document
September 28, 2021 Filed Oct 1, 2021 00:17 UTC
Mathew Aby J.Exec VP & Chief Scientific Off
SaleCommon Stock 719 $43.12 $31,003.28
Disclosure

SEC source: 0001437749-21-022970 · rdgdoc.xml · nonDerivative · entry 1

Mathew Aby J. · CIK 0001556355 · Exec VP & Chief Scientific Off

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 208,471

F1 · kind: The sale reported herein was made by the issuer to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
September 28, 2021 Filed Oct 1, 2021 00:17 UTC
Foster Karen A.Chief Quality Officer
SaleCommon Stock 610 $43.12 $26,303.20
Disclosure

SEC source: 0001437749-21-022969 · rdgdoc.xml · nonDerivative · entry 1

Foster Karen A. · CIK 0001683151 · Chief Quality Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,842

F1 · kind: The sale reported herein was made by the issuer to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
September 28, 2021 Filed Oct 1, 2021 00:17 UTC
Rice MichaelDirector · CEO
SaleCommon Stock 907 $43.12 $39,109.84
Disclosure

SEC source: 0001437749-21-022968 · rdgdoc.xml · nonDerivative · entry 1

Rice Michael · CIK 0001389512 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 264,555

F1 · kind: The sale reported herein was made by the issuer to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
September 28, 2021 Filed Oct 1, 2021 00:16 UTC SaleCommon Stock 689 $43.12 $29,709.68
Disclosure

SEC source: 0001437749-21-022967 · rdgdoc.xml · nonDerivative · entry 1

DE GREEF RODERICK · CIK 0001241181 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 127,925

F1 · kind: The sale reported herein was made by the issuer to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
September 28, 2021 Filed Oct 1, 2021 00:16 UTC
Berard ToddChief Marketing Officer
SaleCommon Stock 505 $43.12 $21,775.60
Disclosure

SEC source: 0001437749-21-022966 · rdgdoc.xml · nonDerivative · entry 1

Berard Todd · CIK 0001633186 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 78,559

F1 · kind: The sale reported herein was made by the issuer to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Read SEC document
September 27, 2021 Filed Sep 30, 2021 00:00 UTC
Foster Karen A.Chief Quality Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 16,332 $0.00 Strike: $1.64 $0.00
Disclosure

SEC source: 0001437749-21-022863 · rdgdoc.xml · derivative · entry 3

Foster Karen A. · CIK 0001683151 · Chief Quality Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,664

Underlying: Common Stock · 16,332 shares

Expires 2021-12-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: On December 20, 2016, the reporting person was granted an option to purchase 163,323 shares of common stock which vested in two equal installments on March 8, 2018 and March 8, 2019.

Read SEC document
September 27, 2021 Filed Sep 30, 2021 00:00 UTC
Foster Karen A.Chief Quality Officer
SaleCommon Stock 16,332 $44.66 $729,387.12
Disclosure

SEC source: 0001437749-21-022863 · rdgdoc.xml · nonDerivative · entry 2

Foster Karen A. · CIK 0001683151 · Chief Quality Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,452

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2020.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.08 to $45.65 per share, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
September 27, 2021 Filed Sep 30, 2021 00:00 UTC
Foster Karen A.Chief Quality Officer
Exercise / conversionCommon Stock 16,332 $1.64 $26,784.48
Disclosure

SEC source: 0001437749-21-022863 · rdgdoc.xml · nonDerivative · entry 1

Foster Karen A. · CIK 0001683151 · Chief Quality Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 88,784

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 22, 2021 Filed Sep 23, 2021 00:00 UTC
Mathew Aby J.Exec VP & Chief Scientific Off
Exercise / conversionEmployee Stock Option · Derivative 10,000 $0.00 Strike: $1.64 $0.00
Disclosure

SEC source: 0001437749-21-022535 · rdgdoc.xml · derivative · entry 6

Mathew Aby J. · CIK 0001556355 · Exec VP & Chief Scientific Off

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,853

Underlying: Common Stock · 10,000 shares

Expires 2021-12-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: On December 20, 2016, the reporting person was granted an option to purchase 197,707 shares of common stock which vested in two equal annual installments on March 8, 2018 and March 8, 2019.

Read SEC document
September 22, 2021 Filed Sep 23, 2021 00:00 UTC
Mathew Aby J.Exec VP & Chief Scientific Off
SaleCommon Stock 10,000 $46.99 $469,900.00
Disclosure

SEC source: 0001437749-21-022535 · rdgdoc.xml · nonDerivative · entry 4

Mathew Aby J. · CIK 0001556355 · Exec VP & Chief Scientific Off

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 209,190

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of November 12, 2020.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.32 to $47.44, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
September 22, 2021 Filed Sep 23, 2021 00:00 UTC
Mathew Aby J.Exec VP & Chief Scientific Off
Exercise / conversionCommon Stock 10,000 $1.64 $16,400.00
Disclosure

SEC source: 0001437749-21-022535 · rdgdoc.xml · nonDerivative · entry 3

Mathew Aby J. · CIK 0001556355 · Exec VP & Chief Scientific Off

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 219,190

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 20, 2021 Filed Sep 23, 2021 00:00 UTC
Mathew Aby J.Exec VP & Chief Scientific Off
Exercise / conversionEmployee Stock Option · Derivative 10,000 $0.00 Strike: $1.64 $0.00
Disclosure

SEC source: 0001437749-21-022535 · rdgdoc.xml · derivative · entry 5

Mathew Aby J. · CIK 0001556355 · Exec VP & Chief Scientific Off

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,853

Underlying: Common Stock · 10,000 shares

Expires 2021-12-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: On December 20, 2016, the reporting person was granted an option to purchase 197,707 shares of common stock which vested in two equal annual installments on March 8, 2018 and March 8, 2019.

Read SEC document
September 20, 2021 Filed Sep 23, 2021 00:00 UTC
Mathew Aby J.Exec VP & Chief Scientific Off
SaleCommon Stock 10,000 $46.89 $468,900.00
Disclosure

SEC source: 0001437749-21-022535 · rdgdoc.xml · nonDerivative · entry 2

Mathew Aby J. · CIK 0001556355 · Exec VP & Chief Scientific Off

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 209,190

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of November 12, 2020.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.89 to $47.27, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
September 20, 2021 Filed Sep 23, 2021 00:00 UTC
Mathew Aby J.Exec VP & Chief Scientific Off
Exercise / conversionCommon Stock 10,000 $1.64 $16,400.00
Disclosure

SEC source: 0001437749-21-022535 · rdgdoc.xml · nonDerivative · entry 1

Mathew Aby J. · CIK 0001556355 · Exec VP & Chief Scientific Off

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 219,190

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 16, 2021 Filed Sep 18, 2021 00:00 UTC
Berard ToddChief Marketing Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 6,160 $0.00 Strike: $1.64 $0.00
Disclosure

SEC source: 0001437749-21-022360 · rdgdoc.xml · derivative · entry 6

Berard Todd · CIK 0001633186 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,640

Underlying: Common Stock · 6,160 shares

Expires 2021-12-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: On December 20, 2016, the reporting person was granted an option to purchase 123,209 shares of common stock which vested in two equal annual installments on March 8, 2018 and March 8, 2019.

Read SEC document
September 16, 2021 Filed Sep 18, 2021 00:00 UTC
Berard ToddChief Marketing Officer
SaleCommon Stock 6,160 $46.10 $283,976.00
Disclosure

SEC source: 0001437749-21-022360 · rdgdoc.xml · nonDerivative · entry 4

Berard Todd · CIK 0001633186 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,064

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2020.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.77 to $46.5 per share, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
September 16, 2021 Filed Sep 18, 2021 00:00 UTC
Berard ToddChief Marketing Officer
Exercise / conversionCommon Stock 6,160 $1.64 $10,102.40
Disclosure

SEC source: 0001437749-21-022360 · rdgdoc.xml · nonDerivative · entry 3

Berard Todd · CIK 0001633186 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,224

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 15, 2021 Filed Sep 18, 2021 00:00 UTC
Berard ToddChief Marketing Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 6,160 $0.00 Strike: $1.64 $0.00
Disclosure

SEC source: 0001437749-21-022360 · rdgdoc.xml · derivative · entry 5

Berard Todd · CIK 0001633186 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,800

Underlying: Common Stock · 6,160 shares

Expires 2021-12-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: On December 20, 2016, the reporting person was granted an option to purchase 123,209 shares of common stock which vested in two equal annual installments on March 8, 2018 and March 8, 2019.

Read SEC document
September 15, 2021 Filed Sep 18, 2021 00:00 UTC
Berard ToddChief Marketing Officer
SaleCommon Stock 6,160 $49.01 $301,901.60
Disclosure

SEC source: 0001437749-21-022360 · rdgdoc.xml · nonDerivative · entry 2

Berard Todd · CIK 0001633186 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,064

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2020.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.20 to $49.81 per share, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
September 15, 2021 Filed Sep 18, 2021 00:00 UTC
Berard ToddChief Marketing Officer
Exercise / conversionCommon Stock 6,160 $1.64 $10,102.40
Disclosure

SEC source: 0001437749-21-022360 · rdgdoc.xml · nonDerivative · entry 1

Berard Todd · CIK 0001633186 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,224

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 09, 2021 Filed Sep 10, 2021 00:01 UTC
Rice MichaelDirector · CEO
Exercise / conversionEmployee Stock Option · Derivative 11,461 $0.00 Strike: $1.64 $0.00
Disclosure

SEC source: 0001437749-21-021860 · rdgdoc.xml · derivative · entry 6

Rice Michael · CIK 0001389512 · Director · CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,769

Underlying: Common Stock · 11,461 shares

Expires 2021-12-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The option vested in two equal annual installments based on the registrant's satisfaction of certain performance criteria for the fiscal year ending December 2017. The performance criteria for 2017 were met, resulting in vesting of the option as follows: 114,613 shares vested on March 8, 2018 and 114,613 shares vested on March 8, 2019.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.